| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0001567619-22-010973 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | PERRITT CAPITAL MANAGEMENT INC | 1279342 | PROPHASE LABS INC COM | COM | 74345W108 | 1459 | 208400 | SH | SOLE | 208400 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | ProPhase Labs | Pharmaceuticals & Biotechnology | |||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | PROPHASE LABS INC | COM | 74345W108 | 4 | 500 | SH | DFND | 3 | 500 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | PROPHASE LABS INC | COM | 74345W108 | 205 | 29350 | SH | DFND | 02 | 0 | 0 | 29350 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | PROPHASE LABS INC | COM | 74345W108 | 207 | 29500 | SH | Put | DFND | 2 | 0 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | ProPhase Labs | Pharmaceuticals & Biotechnology | |
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | PROPHASE LABS INC | COM | 74345W108 | 80 | 11434 | SH | DFND | 2 | 11434 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0001062993-22-012655 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CAPTRUST FINANCIAL ADVISORS | 1512024 | PROPHASE LABS INC | COM | 74345W108 | 7 | 1000 | SH | SOLE | 1000 | 0 | 0 | May 17th, 2022 01:42AM | May 17th, 2022 01:42AM | ProPhase Labs | Pharmaceuticals & Biotechnology | |||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | PROPHASE LABS INC | COM | 74345W108 | 125 | 17904 | SH | DFND | 1 | 17904 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | PROPHASE LABS INC | COM | 74345W108 | 0 | 22 | SH | DFND | 22 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | ProPhase Labs | Pharmaceuticals & Biotechnology | |||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0000950123-22-006139 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | AMERIPRISE FINANCIAL INC | 820027 | PROPHASE LABS INC | COM | 74345W108 | 1 | 198 | SH | DFND | 16 | 0 | 0 | 198 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||
| nasdaq:prph | nasdaq:prph Shareholders | 13F-HR | 0000950123-22-006139 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | AMERIPRISE FINANCIAL INC | 820027 | PROPHASE LABS INC | COM | 74345W108 | 964 | 137746 | SH | DFND | 2 | 0 | 137746 | 0 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | ProPhase Labs | Pharmaceuticals & Biotechnology |